Jules M. Coenen
Zwolle, OV, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Integrated analysis of pain, health-related quality of life, and analgesic use in patients with metastatic castration-resistant prostate cancer treated with Radium-223.
Journal: Prostate cancer and prostatic diseases
Published: February 21, 2021
The effects of new life-prolonging drugs for metastatic castration-resistant prostate cancer (mCRPC) patients in a real-world population.
Journal: Prostate cancer and prostatic diseases
Published: October 29, 2020
Third-line Life-prolonging Drug Treatment in a Real-world Metastatic Castration-resistant Prostate Cancer Population: Results from the Dutch Castration-resistant Prostate Cancer Registry.
Journal: European urology focus
Published: December 30, 2019
Hospital-based or home-based administration of oncology drugs? A micro-costing study comparing healthcare and societal costs of hospital-based and home-based subcutaneous administration of trastuzumab.
Journal: Breast (Edinburgh, Scotland)
Published: October 17, 2019
A prospective observational registry evaluating clinical outcomes of Radium-223 treatment in a nonstudy population.
Journal: International journal of cancer
Published: September 21, 2019
Health-related Quality of Life and Pain in a Real-world Castration-resistant Prostate Cancer Population: Results From the PRO-CAPRI Study in the Netherlands.
Journal: Clinical genitourinary cancer
Published: September 12, 2019
Differences in Trial and Real-world Populations in the Dutch Castration-resistant Prostate Cancer Registry.
Journal: European urology focus
Published: June 16, 2016
CAST: A retrospective analysis of cabazitaxel and abiraterone acetate sequential treatment in patients with metastatic castrate-resistant prostate cancer previously treated with docetaxel.
Journal: International journal of cancer
Published: June 29, 2014
Acute left-sided abdominal pain.
Journal: The Netherlands journal of medicine
Published: March 07, 2013
Cabazitaxel in patients with metastatic castration-resistant prostate cancer: results of a compassionate use program in the Netherlands.
Journal: Clinical genitourinary cancer
Published: October 23, 2012
Last Updated: 09/26/2026